Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Abiraterone","url":"https:\/\/www.ortaakarsu.net\/?page_id=12315","facts":[{"label":"Active ingredient \/ generic name","value":"abiraterone"},{"label":"ATC code","value":"L02BX03"},{"label":"Administration route","value":"Oral"}]},{"title":"Rifabutin","url":"https:\/\/www.ortaakarsu.net\/?page_id=12405","facts":[{"label":"Active ingredient \/ generic name","value":"rifabutin"},{"label":"ATC code","value":"J04AB04"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"EMA Zytiga SmPC; retrieved 2026-11-02; SmPC 4.5"}],"sources":[{"label":"Original native interaction source (provenance)","url":"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zytiga-epar-product-information_en.pdf"},{"label":"ZYTIGA official product information","url":"https:\/\/www.jnjlabels.com\/package-insert\/product-monograph\/prescribing-information\/ZYTIGA-pi.pdf"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:28626","available":true}}